Synosense

Supervisor: Prof. Jeroen Lammertyn

Synosense is a team of motivated KU Leuven students with a common passion for science and a desire to help rheumatoid arthritis (RA) patients. In the past few months, we are committed to turning this desire into reality by developing the Synosensor - a sensor for detection of adalimumab (ADM), a life-changing drug for RA patients.

The outcome of our endeavors is an elegant and user-friendly device that can replace an entire lab and allow untrained people to perform a measurement within minutes. To have the readout, the patient only needs to apply a drop of blood on the unique Synochip, activate it with a single push of a button, and place the chip in the Synosensor. Our device takes care of the rest.

Our unique business strategy combines a partnership with a multinational pharmaceutical company and additional novel revenue streams each year to bring our sensor to the market. In addition, Synosense does not only aim to offer a device, but also an entire community-building approach to connect persons living with RA globally for an all-encompassing healing experience.

The Synosensor is a new must-have tool for the doctor’s office, with a promise to improve quality of life for thousands of RA patients.